{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:28:01Z","timestamp":1780471681565,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idc.2022.04.001","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:42:17Z","timestamp":1663267337000},"page":"605-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnostic Testing for Lyme Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Takaaki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Auwaerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0934-8840(98)80124-2","article-title":"Epidemiology of european lyme borreliosis","volume":"287","author":"O'Connell","year":"1998","journal-title":"Zentralbl Bakteriol"},{"issue":"17","key":"10.1016\/j.idc.2022.04.001_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases - united states and territories, 2004-2016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.idc.2022.04.001_bib3","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.idc.2022.04.001_bib4","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","article-title":"The presenting manifestations of lyme disease and the outcomes of treatment","volume":"348","author":"Steere","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14787210.3.4.593","article-title":"Management of severe bacterial infections","volume":"3","author":"Esposito","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3201\/eid2007.131587","article-title":"Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern united states","volume":"20","author":"Krause","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"21","key":"10.1016\/j.idc.2022.04.001_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9343(99)00046-7","article-title":"Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast united states","volume":"106","author":"Hilton","year":"1999","journal-title":"Am J Med"},{"issue":"31","key":"10.1016\/j.idc.2022.04.001_bib9","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of lyme disease","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0033354919890024","article-title":"Evaluating the potential misuse of the lyme disease surveillance case definition","volume":"135","author":"Perea","year":"2020","journal-title":"Public Health Rep"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib11","doi-asserted-by":"crossref","first-page":"e20171975","DOI":"10.1542\/peds.2017-1975","article-title":"Accuracy of clinician suspicion of lyme disease in the emergency department","volume":"140","author":"Nigrovic","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3201\/eid2203.151273","article-title":"Lyme disease in hispanics, united states, 2000-2013","volume":"22","author":"Nelson","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2022.04.001_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3201\/eid1905.120796","article-title":"Atypical erythema migrans in patients with pcr-positive lyme disease","volume":"19","author":"Schutzer","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib14","doi-asserted-by":"crossref","first-page":"ofz299","DOI":"10.1093\/ofid\/ofz299","article-title":"Misdiagnosis of lyme disease with unnecessary antimicrobial treatment characterizes patients referred to an academic infectious diseases clinic","volume":"6","author":"Kobayashi","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2021.10.040","article-title":"Mistaken identity: Many diagnoses are frequently misattributed to lyme disease","volume":"135","author":"Kobayashi","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2022.04.001_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpeds.2016.04.004","article-title":"False positive lyme disease igm immunoblots in children","volume":"174","author":"Lantos","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive igm immunoblots for borrelia burgdorferi in clinical practice","volume":"18","author":"Seriburi","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3201\/eid2207.151694","article-title":"Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of lyme disease, united states","volume":"22","author":"Moore","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib19","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1016\/j.healun.2015.01.856","article-title":"Mycobacterium abscessus and lung transplantation: an international survey","volume":"34","author":"Bills","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.idc.2022.04.001_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of america","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of america (idsa), american academy of neurology (aan), and american college of rheumatology (acr): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/cid\/cix943","article-title":"Advances in serodiagnostic testing for lyme disease are at hand","volume":"66","author":"Branda","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2022.04.001_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/JCM.03394-15","article-title":"The past, present, and (possible) future of serologic testing for lyme disease","volume":"54","author":"Theel","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2022.04.001_bib24","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme borreliosis serology: Performance of several commonly used laboratory diagnostic tests and a large resource panel of well-characterized patient samples","volume":"54","author":"Molins","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the c6 peptide elisa kit compared with two-tier testing for lyme disease","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early lyme disease","volume":"33","author":"Engstrom","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00430-013-0315-0","article-title":"Utility of serodiagnostics designed for use in the united states for detection of lyme borreliosis acquired in europe and vice versa","volume":"203","author":"Wormser","year":"2014","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","article-title":"Erythema chronicum migrans and lyme arthritis. The enlarging clinical spectrum","volume":"86","author":"Steere","year":"1977","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/CVI.00109-08","article-title":"Impact of clinical variables on borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in north america with culture-confirmed early lyme disease","volume":"15","author":"Wormser","year":"2008","journal-title":"Clin Vaccin Immunol"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of lyme disease","volume":"167","author":"Dressler","year":"1993","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/174.2.346","article-title":"Serodiagnosis of lyme disease: accuracy of a two-step approach using a flagella-based elisa and immunoblotting","volume":"174","author":"Johnson","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib32","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation","volume":"52","author":"Molins","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib33","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1128\/JCM.01853-13","article-title":"Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations","volume":"51","author":"Wormser","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7326\/0003-4819-127-12-199712150-00011","article-title":"Laboratory evaluation in the diagnosis of lyme disease","volume":"127","author":"Tugwell","year":"1997","journal-title":"Ann Intern Med"},{"issue":"32","key":"10.1016\/j.idc.2022.04.001_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated cdc recommendation for serologic diagnosis of lyme disease","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cix043","article-title":"Evaluation of modified 2-tiered serodiagnostic testing algorithms for early lyme disease","volume":"64","author":"Branda","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a vlse c6 peptide enzyme immunoassay","volume":"53","author":"Branda","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","article-title":"Performance of united states serologic assays in the diagnosis of lyme borreliosis acquired in europe","volume":"57","author":"Branda","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib39","doi-asserted-by":"crossref","first-page":"e01841-19","DOI":"10.1128\/JCM.01841-19","article-title":"Performance of a modified two-tiered testing enzyme immunoassay algorithm for serologic diagnosis of lyme disease in nova scotia","volume":"58","author":"Davis","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2022.04.001_bib40","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/civ584","article-title":"Poor positive predictive value of lyme disease serologic testing in an area of low disease incidence","volume":"61","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/156.1.183","article-title":"Cross-reactivity in serological tests for lyme disease and other spirochetal infections","volume":"156","author":"Magnarelli","year":"1987","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a114864","article-title":"Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to borrelia burgdorferi","volume":"127","author":"Magnarelli","year":"1988","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02561539","article-title":"Epstein-barr virus and cytomegalovirus infections cause false-positive results in igm two-test protocol for early lyme borreliosis","volume":"27","author":"Goossens","year":"1999","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CVI.00367-10","article-title":"Acute parvovirus b19 infection causes nonspecificity frequently in borrelia and less often in salmonella and campylobacter serology, posing a problem in diagnosis of infectious arthropathy","volume":"18","author":"Tuuminen","year":"2011","journal-title":"Clin Vaccin Immunol"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cid\/cix298","article-title":"Early disseminated lyme disease causing false-positive serology for primary epstein-barr virus infection: Report of 2 cases","volume":"65","author":"Pavletic","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diagmicrobio.2015.11.019","article-title":"Cross-reactivity between lyme and syphilis screening assays: Lyme disease does not cause false-positive syphilis screens","volume":"84","author":"Patriquin","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib47","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/521256","article-title":"Reinfection in patients with lyme disease","volume":"45","author":"Nadelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin m or immunoglobulin g antibody responses to borrelia burgdorferi 10-20 years after active lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8513","key":"10.1016\/j.idc.2022.04.001_bib49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(86)90640-9","article-title":"Reinfection with borrelia burgdorferi","volume":"2","author":"Pfister","year":"1986","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.idc.2022.04.001_bib50","first-page":"1069","article-title":"A\u00a0decline in c6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated lyme borreliosis","volume":"12","author":"Philipp","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CVI.13.4.525-529.2006","article-title":"A\u00a0decrease in the immunoglobulin g antibody response against the vlse protein of borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early lyme disease","volume":"13","author":"Marangoni","year":"2006","journal-title":"Clin Vaccin Immunol"},{"issue":"11","key":"10.1016\/j.idc.2022.04.001_bib52","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1128\/CVI.00383-12","article-title":"Misdiagnosis of late-onset lyme arthritis by inappropriate use of borrelia burgdorferi immunoblot testing with synovial fluid","volume":"19","author":"Barclay","year":"2012","journal-title":"Clin Vaccin Immunol"},{"issue":"5","key":"10.1016\/j.idc.2022.04.001_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(15)00464-8","article-title":"Identification of a novel pathogenic borrelia species causing lyme borreliosis with unusually high spirochaetaemia: A descriptive study","volume":"16","author":"Pritt","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib54","doi-asserted-by":"crossref","first-page":"513 e1","DOI":"10.1016\/j.cmi.2019.07.026","article-title":"Borrelia miyamotoi infection leads to cross-reactive antibodies to the c6 peptide in mice and men","volume":"26","author":"Koetsveld","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib56","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/JCM.00350-11","article-title":"Improving the yield of blood cultures from patients with early lyme disease","volume":"49","author":"Liveris","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib57","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.43.10.5080-5084.2005","article-title":"Two-year evaluation of borrelia burgdorferi culture and supplemental tests for definitive diagnosis of lyme disease","volume":"43","author":"Coulter","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/mp.50.4.186","article-title":"A\u00a0two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of lyme borreliosis","volume":"50","author":"Picken","year":"1997","journal-title":"Mol Pathol"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/JCM.40.4.1249-1253.2002","article-title":"Quantitative detection of borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: Correlation of results with clinical and laboratory findings","volume":"40","author":"Liveris","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2022.04.001_bib60","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/648076","article-title":"Blood cultures for patients with extracutaneous manifestations of lyme disease in the united states","volume":"49","author":"Nowakowski","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib61","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/JCM.00410-08","article-title":"Validation of cultivation and pcr methods for diagnosis of lyme neuroborreliosis","volume":"46","author":"Cerar","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"Efns guidelines on the diagnosis and management of european lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-104-6-798","article-title":"Borrelia burgdorferi in joint fluid in chronic lyme arthritis","volume":"104","author":"Snydman","year":"1986","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib65","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/art.30384","article-title":"Burden and viability of borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/174.3.623","article-title":"Detection of borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in lyme neuroborreliosis","volume":"174","author":"Nocton","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib67","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1542\/peds.2012-2531","article-title":"Distinguishing lyme from septic knee monoarthritis in lyme disease-endemic areas","volume":"131","author":"Deanehan","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib68","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for lyme disease","volume":"47","author":"Steere","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9814","key":"10.1016\/j.idc.2022.04.001_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib70","first-page":"630","article-title":"Cerebrospinal fluid findings in adults with acute lyme neuroborreliosis","volume":"259","author":"Djukic","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib71","first-page":"155","article-title":"Csf findings in lyme meningitis","volume":"25","author":"Lakos","year":"1992","journal-title":"J\u00a0Infect"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib72","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","article-title":"Central nervous system abnormalities in lyme neuroborreliosis","volume":"41","author":"Halperin","year":"1991","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.idc.2022.04.001_bib73","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.45.9.1663","article-title":"Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis","volume":"45","author":"Tumani","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib74","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CVI.00341-09","article-title":"Humoral immune responses in patients with lyme neuroborreliosis","volume":"17","author":"Cerar","year":"2010","journal-title":"Clin Vaccin Immunol"},{"issue":"6","key":"10.1016\/j.idc.2022.04.001_bib75","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/infdis\/161.6.1203","article-title":"Evaluation of the intrathecal antibody response to borrelia burgdorferi as a diagnostic test for lyme neuroborreliosis","volume":"161","author":"Steere","year":"1990","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib76","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis-epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib77","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","article-title":"Clinical usefulness of intrathecal antibody testing in acute lyme neuroborreliosis","volume":"14","author":"Ljostad","year":"2007","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.idc.2022.04.001_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1288\/00005537-198511000-00009","article-title":"Facial paralysis in lyme disease","volume":"95","author":"Clark","year":"1985","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2016.0101","article-title":"Chemokine cxc ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for lyme neuroborreliosis: A meta-analysis","volume":"37","author":"Yang","year":"2017","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cid\/ciy019","article-title":"Neuroimmunomodulators in neuroborreliosis and lyme encephalopathy","volume":"67","author":"Eckman","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2022.04.001_bib81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","article-title":"Cxcl13 chemokine in pediatric and adult neuroborreliosis","volume":"124","author":"Wutte","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.idc.2022.04.001_bib82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"Cxcl13 and neopterin concentrations in cerebrospinal fluid of patients with lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J\u00a0Neuroinflammation"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib83","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in lyme neuroborreliosis","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin Vaccin Immunol"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib84","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A\u00a0prospective study on the role of cxcl13 in lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib85","article-title":"Cerebrospinal fluid cxcl13 in lyme neuroborreliosis and asymptomatic hiv infection","volume":"13","author":"Bremell","year":"2013","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1016\/j.idc.2022.04.001_bib86","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-115-7-533","article-title":"The t-cell proliferative assay in the diagnosis of lyme disease","volume":"115","author":"Dressler","year":"1991","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib87","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1128\/IAI.69.12.7437-7444.2001","article-title":"Cellular and humoral immune responses to borrelia burgdorferi antigens in patients with culture-positive early lyme disease","volume":"69","author":"Vaz","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.idc.2022.04.001_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404007276","article-title":"Lyme borreliosis (lyme disease): Molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment","volume":"6","author":"Auwaerter","year":"2004","journal-title":"Expert Rev Mol Med"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib89","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciw112","article-title":"Detection of ifn-gamma secretion by t\u00a0cells collected before and after successful treatment of early lyme disease","volume":"62","author":"Callister","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.04.001_bib90","article-title":"Immunosequencing of the t-cell receptor repertoire reveals signatures specific for diagnosis and characterization of early lyme disease","author":"Greissl","year":"2021","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib91","doi-asserted-by":"crossref","first-page":"e93243","DOI":"10.1371\/journal.pone.0093243","article-title":"Serum inflammatory mediators as markers of human lyme disease activity","volume":"9","author":"Soloski","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cells2030607","article-title":"An enhanced elispot assay for sensitive detection of antigen-specific t\u00a0cell responses to borrelia burgdorferi","volume":"2","author":"Jin","year":"2013","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib93","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2249.1995.tb03134.x","article-title":"The outer surface proteins of lyme disease borrelia spirochetes stimulate t\u00a0cells to secrete interferon-gamma (ifn-gamma): Diagnostic and pathogenic implications","volume":"101","author":"Forsberg","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.idc.2022.04.001_bib94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10067-014-2706-z","article-title":"Characteristics of seroconversion and implications for diagnosis of post-treatment lyme disease syndrome: Acute and convalescent serology among a prospective cohort of early lyme disease patients","volume":"34","author":"Rebman","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib95","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/cid\/ciab503","article-title":"Detection of ifn-gamma secretion in blood samples collected before and after treatment of varying stages of lyme disease","volume":"73","author":"Arnaboldi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmi.2019.06.033","article-title":"Unconventional diagnostic tests for lyme borreliosis: a systematic review","volume":"26","author":"Raffetin","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib97","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1086\/324490","article-title":"Laboratory diagnostic techniques for patients with early lyme disease associated with erythema migrans: A comparison of different techniques","volume":"33","author":"Nowakowski","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2022.04.001_bib98","doi-asserted-by":"crossref","first-page":"e0168613","DOI":"10.1371\/journal.pone.0168613","article-title":"The accuracy of diagnostic tests for lyme disease in humans, a systematic review and meta-analysis of north american research","volume":"11","author":"Waddell","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.idc.2022.04.001_bib100","doi-asserted-by":"crossref","first-page":"e01943-17","DOI":"10.1128\/JCM.01943-17","article-title":"Evaluation of modified two-tiered testing algorithms for lyme disease laboratory diagnosis using well-characterized serum samples","volume":"56","author":"Pegalajar-Jurado","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2022.04.001_bib101","doi-asserted-by":"crossref","first-page":"e36825","DOI":"10.1371\/journal.pone.0036825","article-title":"Direct molecular detection and genotyping of borrelia burgdorferi from whole blood of patients with early lyme disease","volume":"7","author":"Eshoo","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2022.04.001_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/vbz.2019.2547","article-title":"The lyme disease polymerase chain reaction test has low sensitivity","volume":"20","author":"Nigrovic","year":"2020","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14737159.2016.1246959","article-title":"Progress in the molecular diagnosis of lyme disease","volume":"17","author":"Ruzic-Sabljic","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.idc.2022.04.001_bib105","doi-asserted-by":"crossref","first-page":"e01406-18","DOI":"10.1128\/JCM.01406-18","article-title":"Limitations and confusing aspects of diagnostic testing for neurologic lyme disease in the united states","volume":"57","author":"Theel","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2022.04.001_bib106","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/01.wnl.0000269672.17807.e0","article-title":"Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients","volume":"69","author":"Blanc","year":"2007","journal-title":"Neurology"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202200037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202200037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:12Z","timestamp":1760196672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089155202200037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S089155202200037X"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.04.001","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Testing for Lyme Disease","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}